Article Text
Letter
A cell-based bioassay for circulating bioactive IL-17: application to destruction in rheumatoid arthritis
Statistics from Altmetric.com
Footnotes
Contributors NN-T: experiments and writing; PM: concept and writing.
Funding NN-T is supported by the IHU prometteur OPERA. PM is a senior member of and supported by the Institut Universitaire de France.
Competing interests NN-T and PM hold a patent on the determination of bioactive IL-17.
Patient consent Obtained.
Ethics approval Ethics committee of the hospitals of Lyon.
Provenance and peer review Not commissioned; externally peer reviewed.